ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Hot Features

Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.

GTHX G1 Therapeutics Inc

4,49
0,05 (1,13%)
03 Mai 2024 - Fechado
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
G1 Therapeutics Inc GTHX NASDAQ Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
0,05 1,13% 4,49 21:00:00
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
4,56 4,48 4,70 4,49 4,44
mais cotações »

Notícias Recentes

Data Hora Fonte Título
01/05/202418:50GLOBEG1 Therapeutics Announces Inducement Grants Under Nasdaq..
01/05/202407:30GLOBEG1 Therapeutics Provides First Quarter 2024 Financial..
01/05/202407:25GLOBEG1 Therapeutics and Pepper Bio Announce Global (Excluding..
17/04/202410:00GLOBEG1 Therapeutics to Release First Quarter 2024 Financial..
04/04/202411:30GLOBEG1 Therapeutics to Participate in the 23rd Annual Needham..
01/04/202417:20GLOBEG1 Therapeutics Announces Inducement Grants Under Nasdaq..
01/03/202418:20GLOBEG1 Therapeutics Announces Inducement Grants Under Nasdaq..
28/02/202408:30GLOBEG1 Therapeutics Provides Fourth Quarter and Full Year 2023..
27/02/202410:30GLOBEG1 Therapeutics to Participate in the TD Cowen 44th Annual..
15/02/202410:30GLOBEG1 Therapeutics to Release Fourth Quarter and Full Year 2023..
12/02/202418:05GLOBEG1 Therapeutics to Continue Pivotal Phase 3 Trial of..
08/01/202408:45GLOBEG1 Therapeutics Provides Corporate Update at the 42nd Annual..
03/01/202411:00GLOBEG1 Therapeutics to Participate in the 42nd Annual J.P...
02/01/202418:51GLOBEG1 Therapeutics Announces Inducement Grants Under Nasdaq..
05/12/202311:26GLOBEG1 Therapeutics Presents New Post Hoc Analyses Indicating..
01/12/202318:27GLOBEG1 Therapeutics Announces Inducement Grants Under Nasdaq..
29/11/202322:37GLOBEG1 Therapeutics Announces Upcoming Presentation at the 2023..
01/11/202307:30GLOBEG1 Therapeutics Provides Third Quarter 2023 Financial..
27/10/202308:00GLOBEReal World Data Indicate That Trilaciclib Reduces..
18/10/202309:00GLOBEG1 Therapeutics’ COSELA® (trilaciclib) Recommended in..
18/10/202308:30GLOBEG1 Therapeutics to Release Third Quarter 2023 Financial..
16/10/202310:00GLOBEG1 Therapeutics Announces Upcoming Presentations at the 2023..
18/09/202308:00GLOBEBlack Diamond Therapeutics Announces CEO Transition
05/09/202312:00GLOBEG1 Therapeutics to Participate in the H.C. Wainwright 25th..
01/09/202317:15GLOBEG1 Therapeutics Announces Inducement Grants Under Nasdaq..
02/08/202307:30GLOBEG1 Therapeutics Provides Second Quarter 2023 Financial..
31/07/202315:30GLOBEG1 Therapeutics to Participate in Two August Investor..
31/07/202309:30GLOBENew Publication Highlights Real World Impact of Trilaciclib..
26/07/202310:00GLOBEG1 Therapeutics to Release Second Quarter 2023 Financial..
06/07/202317:15GLOBEG1 Therapeutics Announces Inducement Grants Under Nasdaq..
04/06/202308:13GLOBETrilaciclib Increases Pool of Memory T Cells in the Tumor..
01/06/202317:40GLOBEG1 Therapeutics Announces Inducement Grants Under Nasdaq..
22/05/202317:45GLOBEG1 Therapeutics Announces Appointment of Monica Thomas as..
16/05/202308:30GLOBENew Study Confirms Consistent Risk of Myelosuppression..
10/05/202308:31GLOBENew Results from Phase 2 Trial Confirm Benefit of..

Seu Histórico Recente

Delayed Upgrade Clock